AGT Biosciences changes name to Chemgenex

By Melissa Trudinger
Tuesday, 29 June, 2004

AGT Biosciences has completed the last step in its merger with ChemGenex Therapeutics with the official name change of the company going through. Approval by AGT shareholders was obtained last week at an EGM.

From today, the company is to be known as ChemGenex Pharmaceuticals and will carry the ASX stock symbol 'CXS'.

Quitting smoking increases life expectancy even for seniors

Although the benefits of quitting smoking diminish with age, there are still substantial gains...

Stem cell transplants treat blindness in mini pigs

Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...

Sugary drinks raise cardiovascular disease risk, but occasional sweets don't

Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...

Content from other channels on our network

Advanced method to detect harbour sewage

Fighting waste by counting flies

Can we really 'electrify everything'?

'Tis the season for sustainable food at Christmas

Sustainable organic batteries for future energy storage

Refrigerant guide for heat pump selection

D'Orsogna to expand meat processing facilities in WA

Kokumi chemistry for rich-tasting sparkling wines

Suntory Oceania's CEO Darren Fullerton to retire in 2025

Grant Thornton's Dealtracker report for Ag, F&B sector

Why data access holds the key to better care

Closing cybersecurity loopholes — lessons from the US

Virus samples missing from Qld lab, investigation launched

Too much UPF could speed up biological ageing

Patient-specific 3D models to assist in surgery